Yoshiko Shimizu Selected Research

Yoshiko Shimizu Research Topics

Disease

14	Neoplasms (Cancer) 12/2018 - 05/2011
5	Carcinogenesis 01/2020 - 02/2013
4	Urinary Bladder Neoplasms (Bladder Cancer) 03/2023 - 07/2016
4	Breast Neoplasms (Breast Cancer) 05/2020 - 01/2012
2	Squamous Cell Carcinoma of Head and Neck 01/2014 - 08/2013
1	Ocular Hypertension (Glaucoma, Suspect) 01/2024
1	Non-Muscle Invasive Bladder Neoplasms 11/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Triple Negative Breast Neoplasms 04/2016
1	Neoplasm Metastasis (Metastasis) 04/2016
1	Tics (Tic) 04/2016
1	Adenocarcinoma 03/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2013
1	Hypertension (High Blood Pressure) 02/2013
1	Inflammation (Inflammations) 12/2011
1	Aneuploidy (Aneuploid) 05/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2011
1	Ovarian Neoplasms (Ovarian Cancer) 11/2010
1	Down Syndrome (Down's Syndrome) 09/2005
1	Bruxism 09/2003
1	Dyssomnias (Dyssomnia) 05/2003

Drug/Important Bio-Agent (IBA)

6	sphingosine kinaseIBA 12/2018 - 02/2013
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
4	SphingolipidsIBA 12/2018 - 12/2011
4	Proteins (Proteins, Gene)FDA Link 11/2017 - 11/2010
3	CarcinogensIBA 01/2020 - 01/2012
3	EnzymesIBA 01/2014 - 12/2011
2	Plasminogen Activators (Plasminogen Activator)IBA 03/2023 - 01/2020
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 07/2016
2	Plasminogen Activator Inhibitor 1IBA 01/2020 - 11/2017
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2017 - 02/2013
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2017 - 01/2017
2	AzoxymethaneIBA 12/2017 - 01/2017
2	GemininIBA 04/2016 - 05/2011
2	Messenger RNA (mRNA)IBA 03/2012 - 01/2012
2	SurvivinIBA 01/2012 - 11/2010
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2003 - 05/2003
1	Retinaldehyde (Retinal)IBA 01/2024
1	olaparibIBA 05/2020
1	Plasminogen Activator Inhibitor 2IBA 01/2020
1	SerpinsIBA 01/2020
1	Estrogen ReceptorsIBA 12/2018
1	Epidermal Growth Factor (EGF)IBA 12/2018
1	Claudin-2IBA 12/2018
1	Dinoprostone (PGE2)FDA Link 12/2017
1	angiogeninIBA 07/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2016
1	ErbB Receptors (EGF Receptor)IBA 12/2015
1	ChemokinesIBA 01/2015
1	Chemokine CXCL1IBA 01/2015
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2014
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2014
1	SphingosineIBA 01/2014
1	Celecoxib (Celebrex)FDA Link 02/2013
1	Prostaglandins EIBA 02/2013
1	p38 Mitogen-Activated Protein KinasesIBA 02/2013
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2013
1	Angiotensin IIIBA 02/2013
1	VimentinIBA 01/2012
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2012
1	Trastuzumab (Herceptin)FDA Link 01/2012
1	CeramidesIBA 12/2011
1	DNA (Deoxyribonucleic Acid)IBA 05/2011
1	Cisplatin (Platino)FDA LinkGeneric 11/2010
1	Transcription Factors (Transcription Factor)IBA 09/2005
1	Fluvoxamine (Luvox)FDA LinkGeneric 09/2003

Therapy/Procedure

7	Therapeutics 05/2020 - 12/2011
3	Chemoprevention 12/2018 - 02/2013
2	Drug Therapy (Chemotherapy) 12/2011 - 11/2010